Related Experiment Videos
Myelofibrosis in severe combined immunodeficiency due to vitamin D deficiency rickets
Y A al-Eissa1, S A al-Mashhadani
1Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Insights
Severe combined immunodeficiency (SCID) in an infant led to anemia and thrombocytopenia due to vitamin D deficiency. Treatment with 1,25-dihydroxycholecalciferol resolved blood issues but not infections.
Area of Science:
- Pediatric Hematology
- Immunology
- Nutritional Deficiencies
Background:
- Severe combined immunodeficiency (SCID) presents a critical challenge in pediatric care.
- Hematologic abnormalities can complicate the clinical course of infants with primary immune deficiencies.
Observation:
- An infant with SCID developed refractory anemia and thrombocytopenia after six months of age.
- The infant experienced poor growth, recurrent respiratory infections, and diarrhea, requiring frequent transfusions.
Findings:
- Bone marrow biopsy revealed myelofibrosis secondary to severe vitamin D deficiency as the cause of hematologic abnormalities.
- Administration of 1,25-dihydroxycholecalciferol corrected the anemia and thrombocytopenia and improved skeletal findings.
Implications:
- Highlights the potential for nutritional deficiencies, like vitamin D deficiency, to cause significant hematologic complications in immunocompromised infants.
- Underscores the importance of comprehensive nutritional assessment in infants with SCID and complex symptoms.
- Despite hematologic recovery, susceptibility to infections remained a critical factor influencing patient outcomes.
Abstract:
An infant with severe combined immunodeficiency is described in whom a refractory anemia and thrombocytopenia developed after the age of 6 months, associated with poor growth and frequent episodes of upper respiratory tract infections and diarrhea. He required frequent blood and platelet transfusions. Bone marrow biopsy provided evidence that the anemia and thrombocytopenia were the results of myelofibrosis which was secondary to vitamin D deficiency. Therapy with 1,25-dihydroxycholecalciferol resulted in resolution of the hematologic and skeletal abnormalities, but he remained susceptible to recurrent serious infections and died at the age of 13 months.